Quinoline

Quinoline

SCHEMBL1591955

CO.c1ccc2ncccc2c1

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.85
CASP1 P29466 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
CASP7 P55210 1/20 0.54
NPC1 O15118 2/20 0.52
POLB P06746 2/20 0.52
RAB9A P51151 1/20 0.52
CYP3A4 P08684 2/20 0.50
KDM4E B2RXH2 3/20 0.48
HTT P42858 4/20 0.48
CYP1A2 P05177 3/20 0.48
MAPT P10636 3/20 0.48
TP53 P04637 2/20 0.48
HSP90AA1 P07900 2/20 0.48
TSHR P16473 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CYP2C19 P33261 1/20 0.48
NR4A2 P43354 1/20 0.48
HSP90AB1 P08238 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinoline SCHEMBL2791988 0.98 ALDH1A1 (0.81) ALDH1A1CASP1MEN1KMT2ACASP7
Quinoline SCHEMBL28201145 0.98 ALDH1A1 (0.81) ALDH1A1CASP1MEN1KMT2ACASP7
Quinoline SCHEMBL27750922 0.95 ALDH1A1 (0.94) ALDH1A1CASP1MEN1KMT2ACASP7
Quinoline SCHEMBL9684173 0.92 ALDH1A1 (0.90) ALDH1A1CASP1MEN1KMT2ACASP7
Quinoline SCHEMBL7208557 0.92 ALDH1A1 (0.90) ALDH1A1CASP1MEN1KMT2ACASP7
Quinoline SCHEMBL29822171 0.92 ALDH1A1 (1.00) ALDH1A1CASP1MEN1KMT2ACASP7
Quinoline SCHEMBL29349552 0.92 ALDH1A1 (1.00) ALDH1A1CASP1MEN1KMT2ACASP7
Quinoline SCHEMBL32661377 0.92 ALDH1A1 (1.00) ALDH1A1CASP1MEN1KMT2ACASP7
Quinoline SCHEMBL2774 0.92 ALDH1A1 (1.00) ALDH1A1CASP1MEN1KMT2ACASP7
Quinoline SCHEMBL1270969 0.92 ALDH1A1 (1.00) ALDH1A1CASP1MEN1KMT2ACASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108610327-A With the active substd quinolines first alcohol compound of reversing tumor cells resistance and its synthetic method and application 河南师范大学 2018-10-02 CN claimed
CN-108452304-A The preparation method of conversion composite nano materials and product and application on rare earth 浙江大学 2018-08-28 CN claimed
CN-104829439-B A kind of (Z, Z, E) -7, the synthetic method of 11,13- ten six three olefine aldehydrs of carbon 宁波纽康生物技术有限公司 2018-06-12 CN claimed
CN-104840961-B Cancer stem cell sensitive agent is preparing the application in anticancer stem cell test kit MA LIWEI (CN) 2016-03-23 CN claimed
CN-104840961-A Application of cancer stem cell sensitive agent in preparation of anti-cancer stem cell kit MA LIWEI 2015-08-19 CN claimed
CN-103053549-A Photoactivated solenopsis invicta insecticide UNIV SOUTH CHINA AGRICULT 2013-04-24 CN claimed
US-20110092488-A1 Quninoline Methanol Compounds for the Treatment and Prevention of Parasitic Infections DOW GEOFFREY 2011-04-21 US claimed
WO-2010144101-A1 NEXT GENERATION QUINOLOINE METHANOLS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY, ON BEHALF OF U.S. (US) 2010-12-16 WO claimed
WO-2010144102-A1 PENTAFLUOROSULFANYL ANALOGS OF MEFLOQUINE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY, ON BEHALF OF U.S. ARMY MEDICAL RESEARCH AND MATERIAL COMMAND (US) 2010-12-16 WO claimed
WO-2008060269-A2 QUINOLINE METHANOL COMPOUNDS FOR THE TREATMENT AND PREVENTION OF PARASITIC INFECTIONS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2008-05-22 WO claimed
CN-1316279-A X-ray magnetic therapy machine for PDT therapy of cancer by combining radiatherapy with chemicotherapy and its medicine DONG SEN (CN) 2001-10-10 CN claimed
US-4076537-A Light-sensitive materials containing organo tellurium or selenium compounds and sensitizers FUJI PHOTO FILM CO., LTD. (JA) 1978-02-28 US claimed
JP-56086182-A None JP disclosed
CN-119869610-A Preparation method of catalyst and preparation method of ethyl orthosilicate 华陆工程科技有限责任公司 2025-04-25 CN disclosed
CN-119223695-A Method and device for trapping nicotine in flue gas 中国烟草总公司郑州烟草研究院 2024-12-31 CN disclosed
CN-108383780-B Refining method of pitavastatin (III) 湖北荆江源制药股份有限公司 2023-01-31 CN disclosed
EP-0107938-A1 Quinoline or hydroquinoline compounds, their preparation and pharmaceutical compostions comprising them KOWA COMPANY, LTD. (JP) 1984-05-09 EP disclosed
WO-1983003970-A1 COMPOUNDS, COMPOSITIONS AND METHOD OF TREATMENT FOR IMPROVING CIRCULATORY PERFORMANCE MAROKO PETER R 1983-11-24 WO disclosed
JP-S5686182-A IMIDAZOLYLETHOXY DERIVATIVE OF QUINOLINE METHANOL SQUIBB & SONS INC 1981-07-13 JP disclosed
US-4076537-A Light-sensitive materials containing organo tellurium or selenium compounds and sensitizers FUJI PHOTO FILM CO., LTD. (JA) 1978-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092488-A1 Quninoline Methanol Compounds for the Treatment and Prevention of Parasitic Infections MTX1, MTX2, NQO2 ALDH1A1 1313/4885CASP1 274/4885MEN1 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.